CIK 0001020214
- Accelerated filer
CERUS CORP
Sign in to watch- Ticker
- CERS
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 680262011
- Phone
- +1 925-288-6000
- Business address
- 1220 CONCORD AVENUE, SUITE 600, CONCORD, CA, 94520
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Chief Medical Officer bought 20,500 shares at an average $2.95 ($60,437)
- 4 Open-market buy Chief Medical Officer bought 60,000 shares at an average $2.94 ($176,340)
- 4 Open-market buy Chief Medical Officer bought 86,900 shares at an average $2.78 ($241,617)
- 4 Open-market buy President and CEO bought 10,000 shares at $2.83 ($28,250)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Medical Officer bought 1,100 shares at an average $2.68 ($2,947)
- 4 Open-market buy Chief Medical Officer bought 2,000 shares at $2.50 ($5,000)
- 4 Open-market buy Chief Medical Officer bought 9,915 shares at an average $2.55 ($25,263)
- 4 Open-market buy Chief Medical Officer bought 20,000 shares at an average $2.69 ($53,878)
- 4 Other disposition Sr. VP Bus. Dev. & Marketing disposed of 1,672 shares (other)
- 4 Other disposition Chief Medical Officer disposed of 2,029 shares (other)
- 4 Other disposition Vice President, Legal Affairs disposed of 1,729 shares (other)
- 4 Other disposition Executive Officer and Director disposed of 5,255 shares (other)
- 4 Derivatives Options or other derivatives
Page 25 of 36 · 701 filings